Implementing health economics for pharmacogenomics research translation in Africa
Open Access
- 20 June 2025
- journal article
- review article
- Published by Springer Nature in Communications Medicine
- Vol. 5 (1) , 1-7
Abstract
Pharmacogenomics studies how a person’s inherited genes influence response to therapeutic drugs. Many drugs do not work in all patients and pharmacogenomics can assist in the identification of patients who are better suited to particular drugs or patients who need adjusted drug doses to reach better treatment outcomes. This stratification of patients could be beneficial in Africa as it would allow drugs that would ordinarily be discontinued due to toxicity on a proportion of the populations to be used in a directed manner in people for whom it is not toxic. However, there has been limited use of pharmacogenomics. One of the key issues has been the need to demonstrate the economic benefits of adopting pharmacogenomics implementation and the impact on healthcare cost drivers. Integration of pharmacogenomics into clinical practice has huge potential in Africa due to the large genetic diversity in African populations. This Perspective article explores the current pharmacogenomics landscape, the health economics associated with its implementation, and future directions for pharmacogenomics research translation in Africa.Keywords
This publication has 57 references indexed in Scilit:
- Clinical implementation of preemptive pharmacogenomics in psychiatryEBioMedicine, 2024
- Cost Effectiveness of Molecular Diagnostic Testing Algorithms for the Treatment Selection of Frontline Ibrutinib for Patients with Chronic Lymphocytic Leukemia in AustraliaApplied Health Economics and Health Policy, 2023
- Why 90% of clinical drug development fails and how to improve it?Acta Pharmaceutica Sinica B, 2022
- Development of a laboratory-based pharmacogenomics independent study and advanced pharmacy practice experience: Connecting basic science to clinical applicationCurrents in Pharmacy Teaching and Learning, 2021
- PharmGKB, an Integrated Resource of Pharmacogenomic KnowledgeCurrent Protocols, 2021
- Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised MedicinePharmacoEconomics, 2021
- Precision pharmacotherapy: Integrating pharmacogenomics into clinical pharmacy practiceJACCP: Journal of the American College of Clinical Pharmacy, 2019
- Using Genomic Information to Guide Ibrutinib Treatment Decisions in Chronic Lymphocytic Leukaemia: A Cost-Effectiveness AnalysisPharmacoEconomics, 2017
- Introduction to health economics and decision-making: Is economics relevant for the frontline clinician?Best Practice & Research Clinical Gastroenterology, 2013
- High prevalence of the CYP2B6 516G→T(*6) variant and effect on the population pharmacokinetics of efavirenz in HIV/AIDS outpatients in ZimbabweEuropean Journal of Clinical Pharmacology, 2007